theMednetRegister
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 Apr 11
Accelerating the Evolution of Immune-Related Enterocolitis Management.   

Related Questions

In a patient with unresectable HCC who developed immune-related colitis with the first dose of tremelimumab/durvalumab, would you consider continuing durvalumab alone after resolution of the colitis with steroid treatment?
Would you consider a colonoscopy?
New comment by Medical Oncologist at Texas Oncology ( August 14, 2025)
Do you routinely do a colonoscopy after the colitis symptoms are gone to document healing, or not?
Copyright © 2025 theMednet
All Rights Reserved.